Browse FOXS1

Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Nucleus
Domain PF00250 Forkhead domain
Function

Transcriptional repressor that suppresses transcription from the FASLG, FOXO3 and FOXO4 promoters. May have a role in the organization of the testicular vasculature (By similarity).

> Gene Ontology
 
Biological Process GO:0035264 multicellular organism growth
GO:0040014 regulation of multicellular organism growth
GO:0040018 positive regulation of multicellular organism growth
GO:0043433 negative regulation of sequence-specific DNA binding transcription factor activity
GO:0045927 positive regulation of growth
GO:0048638 regulation of developmental growth
GO:0048639 positive regulation of developmental growth
GO:0050885 neuromuscular process controlling balance
GO:0050905 neuromuscular process
GO:0051090 regulation of sequence-specific DNA binding transcription factor activity
Molecular Function -
Cellular Component -
> KEGG and Reactome Pathway
 
KEGG -
Reactome -
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between FOXS1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of FOXS1 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of FOXS1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.870.0192
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.7950.35
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.9230.159
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 916-0.1250.826
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.2190.838
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 47-0.5590.653
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.4860.316
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15110.750.31
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.1270.869
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 481.0840.407
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 281.6710.348
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.3110.0332
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of FOXS1 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 277311.12.78.40.12
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 275911.13.47.70.176
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)211705.9-5.90.447
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)131109.1-9.10.458
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38277.907.90.26
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 221313.6013.60.279
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of FOXS1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of FOXS1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by FOXS1.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of FOXS1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of FOXS1 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between FOXS1 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolFOXS1
Nameforkhead box S1
Aliases FREAC10; FKHL18; forkhead (Drosophila)-like 18; forkhead-like 18 (Drosophila); FREAC-10; forkhead-like 18 pr ......
Chromosomal Location20q11.21
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting FOXS1 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.